Huiqing Wang

Huiqing Wang

Auto-generated profile, based on publicly available information

Huiqing Wang

Department of Urology, Shanghai Changhai Hospital, Naval Medical University, Shanghai, China

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 November 2023 in Discover Oncology
Verified
Journal Article
Open access
PDF file
ZLZhizhou Li
Zhizhou Li
MWMaoyu Wang
Maoyu Wang
MHMeimian Hua
Meimian Hua
ZWZiwei Wang
Ziwei Wang
YYYidie Ying
Yidie Ying
CXChuanliang Xu
Chuanliang Xu
Objective: Previous observational studies have explored the correlation between testosterone and cancer risk. However, the causal association between testosterone and various cancer types in women remains inconclusive. The objective of this Mendelian randomization study is to evaluate the causal links between total testosterone (TT) and bioavailable testosterone (BT) with cancer risk in females.Methods: Initially, a rigorous quality control process was employed to identify suitable instrumental single nucleotide polymorphisms (SNPs) associated with the exposure under investigation that exhibited a significant association. The genetic causal relationship between female testosterone levels and the risk of developing cancers was examined through a two-sample Mendelian randomization. Various analytical methods, including inverse-variance weighted (IVW), MR-Egger, weighted median, simple mode, and weighted mode, were applied in the investigation. Key findings were primarily based on the results obtained via IVW (random effects), and sensitivity analyses were conducted to assess the reliability of the obtained results. Furthermore, maximum likelihood, penalized weighted median, and IVW (fixed effects) methods were utilized to further validate the robustness of the results.Results: Based on the results of IVW analysis, our study indicated a positive causal relationship between BT and breast cancer (OR = 1.1407, 95%CI: 1.0627–1.2244, P = 0.0015) and endometrial cancer (OR = 1.4610, 95%CI: 1.2695–1.6813, P = 1.22E-06). Moreover, our findings also showed a positive causal association between TT and breast cancer (OR = 1.1764, 95%CI: 1.0846–1.2761, P = 0.0005), cervical cancer(OR = 1.0020, 95%CI: 1.0007–1.0032, P = 0.0077), and endometrial cancer(OR = 1.4124, 95%CI: 1.2083–1.6511, P = 0.0001). Additionally, our results demonstrated a negative causal relationship between BT and ovarian cancer (OR = 0.8649, 95%CI: 0.7750–0.9653, P = 0.0320). However, no causal relationship was found between BT, TT and other types of cancer (corrected P > 0.05).Conclusions: This study elucidates the role of testosterone on the development of breast cancer, endometrial cancer, ovarian cancer, and cervical cancer. It also hints at a potential but fragile link between testosterone and bladder cancer, as well as thyroid cancer. Nonetheless, it's worth noting that no statistically significant relationship between testosterone and various other types of cancer in females was identified.

7 June 2024 in Cancer Medicine
Verified
Journal Article
Open access
MWMaoyu Wang
Maoyu Wang
ZLZhizhou Li
Zhizhou Li
SZShuxiong Zeng
Shuxiong Zeng
ZWZiwei Wang
Ziwei Wang
YYYidie Ying
Yidie Ying
CXChuanliang Xu
Chuanliang Xu
Objective: We have developed explainable machine learning models to predict the overall survival (OS) of retroperitoneal liposarcoma (RLPS) patients. This approach aims to enhance the explainability and transparency of our modeling results.Methods: We collected clinicopathological information of RLPS patients from The Surveillance, Epidemiology, and End Results (SEER) database and allocated them into training and validation sets with a 7:3 ratio. Simultaneously, we obtained an external validation cohort from The First Affiliated Hospital of Naval Medical University (Shanghai, China). We performed LASSO regression and multivariate Cox proportional hazards analysis to identify relevant risk factors, which were then combined to develop six machine learning (ML) models: Cox proportional hazards model (Coxph), random survival forest (RSF), ranger, gradient boosting with component‐wise linear models (GBM), decision trees, and boosting trees. The predictive performance of these ML models was evaluated using the concordance index (C‐index), the integrated cumulative/dynamic area under the curve (AUC), and the integrated Brier score, as well as the Cox–Snell residual plot. We also used time‐dependent variable importance, analysis of partial dependence survival plots, and the generation of aggregated survival SHapley Additive exPlanations (SurvSHAP) plots to provide a global explanation of the optimal model. Additionally, SurvSHAP (t) and survival local interpretable model‐agnostic explanations (SurvLIME) plots were used to provide a local explanation of the optimal model.Results: The final ML models are consisted of six factors: patient's age, gender, marital status, surgical history, as well as tumor's histopathological classification, histological grade, and SEER stage. Our prognostic model exhibits significant discriminative ability, particularly with the ranger model performing optimally. In the training set, validation set, and external validation set, the AUC for 1, 3, and 5 year OS are all above 0.83, and the integrated Brier scores are consistently below 0.15. The explainability analysis of the ranger model also indicates that histological grade, histopathological classification, and age are the most influential factors in predicting OS.Conclusions: The ranger ML prognostic model exhibits optimal performance and can be utilized to predict the OS of RLPS patients, offering valuable and crucial references for clinical physicians to make informed decisions in advance.

1 January 2025 in The World Journal of Men's Health
Verified
Journal Article
Open access
PDF file
ZLZhizhou Li
Zhizhou Li
MWMaoyu Wang
Maoyu Wang
SZShuxiong Zeng
Shuxiong Zeng
ZWZiwei Wang
Ziwei Wang
YYYidie Ying
Yidie Ying
HWHuiqing Wang
Huiqing Wang
Li Z, et al. World J Mens Health. 2024 Sep;42:e84. https://doi.org/10.5534/wjmh.240062

1 April 2024 in Translational Andrology and Urology
Verified
Journal Article
Open access
PDF file
ZLZhizhou Li
Zhizhou Li
MWMaoyu Wang
Maoyu Wang
WGWei Gang
Wei Gang
YYYidie Ying
Yidie Ying
ZWZiwei Wang
Ziwei Wang
HWHuiqing Wang
Huiqing Wang
Background: Adrenocortical carcinoma (ACC) is an extremely rare and highly invasive malignant tumor. However, there is currently no reliable method to predict the prognosis of ACC. Our objective is to construct a nomogram and a risk classification system to predict the 1-year, 3-year, and 5-year overall survival (OS) of ACC. Methods: We retrieved clinicopathological data of patients diagnosed with ACC in The Surveillance, Epidemiology, and End Results (SEER) database and divided them into training and validation cohorts with a 7:3 ratio. Simultaneously, we collected an external validation cohort from The First Affiliated Hospital of Naval Medical University (Shanghai, China). Univariate and multivariate Cox analyses were performed to identify relevant risk factors, which were then combined to develop a correlation nomogram. The predictive performance of the nomogram was evaluated using the concordance index (C-index), receiver-operating characteristic curve (ROC), and calibration curves. Decision curve analysis (DCA) was applied to assess the clinical utility of the nomogram. In addition, Kaplan-Meier survival curves were generated to demonstrate the variation in OS between groups. Results: The final nomogram consisted of five factors: age, T, N, M, and history of chemotherapy. Our prognostic model demonstrated significant discriminative ability, with C-index and the area under the receiver operating characteristic (AUC) values exceeding 0.70. Additionally, DCA validated the clinical utility of the nomogram. In the entire cohort, the median OS for patients in the low- and high-risk groups was 70 and 10 months, respectively. Conclusions: A nomogram and a corresponding risk classification system were developed in order to predict the OS of patients diagnosed with ACC. These tools have the potential to provide valuable support for patient counseling and assist in the decision-making process related to treatment options.

1 January 2006
Verified
Journal Article
Closed access
HWHui-Qing Wang
Hui-Qing Wang
SWSai-Zhu Wu
Sai-Zhu Wu
YRYun-Jun Ruan
Yun-Jun Ruan
YCYu-Ning Cheng
Yu-Ning Cheng
FSFei Sun
Fei Sun
MYMeng-Zhuo Yin
Meng-Zhuo Yin

2 September 2025 in Bladder
Verified
Journal Article
Open access
PDF file
YWYi Wang
Yi Wang
HWHuiqing Wang
Huiqing Wang
CYChen Ye
Chen Ye
ZZZhensheng Zhang
Zhensheng Zhang
SZShuxiong Zeng
Shuxiong Zeng
CXChuanliang Xu
Chuanliang Xu
Background: Ureteral tumors are rare and present unique diagnostic and therapeutic challenges. Objective: This study aimed to evaluate the efficacy and safety of transurethral resection (TUR) in treating ureteral tumors located in the intramural segment of the bladder wall. Methods: This retrospective study analyzed the clinical data of 24 patients who underwent TUR for intramural ureteral tumors at Changhai Hospital, Shanghai, China, from May 2020 to September 2023. All patients were treated using an “outer wedge, inner rotation” technique, with ureteral stent placed during the procedure. Results: All surgeries were successfully completed, with a median operative time of 45 min (range: 25–75 min), median intraoperative blood loss of 5 mL (range: 1–30 mL), median post-operative hospitalization of 4 days (range: 3–10 days), mean ureteral stent placement duration of 34.1 ± 10.1 days, and a mean tumor resection diameter of 1.9 ± 0.7 cm. There were no intraoperative complications, while post-operative hydronephrosis occurred in 12.5% of patients. Pathological examination revealed that all tumors were urothelial carcinoma, with five cases of Ta stage, one case of pT1 low-grade, 14 cases of pT1 high-grade, and four cases of pT2a high-grade. The median follow-up period lasted for 28 months (range: 11–38 months), with a tumor recurrence rate of 20.8%. Conclusion: TUR of ureteral tumors in the intramural segment is a minimally invasive procedure associated with low blood loss, reduced post-operative complications, and efficacious tumor control while preserving renal function. However, the possibility of local tumor recurrence remains, necessitating close post-operative surveillance.